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Introduction
Metabolic adaptation is linked to life span regulation [1] and important diseases, such as cancer [2] , neurodegeneration [3] and obesity-related disorders [4] . Accordingly, mechanisms of metabolic adaptation represent potential targets for prevention and treatment of disease.
The peroxisome proliferator-activated receptors (PPARs) [5, 6] and the mammalian target of rapamycin (mTOR) [7, 8] are major regulators of metabolism. They converge on the cell survival-associated protein kinase AKT [9] , which is involved in insulin signalling and metabolic balancing. The PPARs crosstalk with central metabolic sensors, such as AMPdependent protein kinase (AMPK) activated upon low energy stress, and PPARγ co-activator 1α (PGC1α) involved in mitochondrial biogenesis, to control adaptive responses [5, 6] . The mTOR protein exists in two complexes, named mTOR complex 1/2 (mTORC1/2), where mTORC1 is the primary nutrient responder [8] . Upon activation, mTORC1 promotes protein translation and cell growth via regulation of the downstream eukaryotic translation initiation factor 4E (eIF4E) and the eIF4E-binding protein 1 (4E-BP1) [10] . Upstream regulators of mTORC1 includes AKT [11] , AMPK [12] and MAP-kinase-extracellular regulated kinase (ERK) [13] .
Metabolic signalling is closely associated with regulation of mitochondrial function and biogenesis. Mitochondria are essential organelles in cellular energy metabolism, and house several catabolic pathways, including fatty acid oxidation, TCA-cycle and mitochondrial respiration. In mitochondrial respiration, electron transport by the respiratory protein complexes is coupled to oxidative phosphorylation yielding ATP from ADP.
Regulation of mitochondrial metabolism and respiration is a crucial mechanism of cellular adaptation, e.g. in response to nutritional alterations or energy depletion. For instance, induction of mitochondrial biogenesis can be observed in muscle as a reaction to physical exercise [14] or mitochondrial mutations [15] , and is linked to the actions of AMPK, PPARs and PGC1α. [16] . Multiple important functions of mitochondrial regulators have previously been characterised in rat liver after nutritional and pharmacological interventions [17] .
Tetradecylthioacetic acid (TTA) is a modified fatty acid that has hypolipidemic effects in rats [18, 19] . This agent activates all the PPAR members, in the ranking order PPARα > PPARδ > PPARγ [19] . Treatment with TTA dramatically increases the mitochondrial oxidative capacity in rat hepatocytes, which seems only partly to be explained by PPARactivation [17, 20] . Here, we used TTA-treatment to investigate the impact and mechanisms of mitochondrial adaptation in relation to key signalling pathways involved in metabolic regulation in rat hepatocytes.
Materials and methods

Materials
TTA was synthesised as described previously [21] . The mtHSP70 and β-actin antibodies were from Abcam (Cambridge, UK), whereas the antibodies for Akt, p-Akt (S473), mTOR 4E-BP1, p-4E-BP1, eIF4G, p-eIF4G, ERK and p-ERK were all from Cell Signaling Technology Inc (Danvers, MA, USA).
Animals and treatments
The animal study was conducted according to the guidelines for the care and use of experimental animals, and the protocol was approved by the Norwegian State Board of Biological Experiments with Living Animals. Eight to ten week old (150-200g) male Wistar rats were obtained from Taconic Europe (Ry, Denmark) and acclimatised for one week prior to experiment. Control groups were given a normal chow diet, while the TTA-treated group were given chow pellets sprayed with 0.3% (w/w) TTA; both groups were fed ad libitum. The daily intake of TTA was estimated to 60 mg based on a consumption of 20 g of feed each day.
For each experiment, two animals in each group were sacrificed, one for collection of biopsies and one for liver perfusion. Hepatocytes were isolated using in vitro collagenase perfusion as previously described [22, 23] .
Transmission electron microscopy (TEM)
Cells and tissue biopsies were fixed in cold 0.1M Na-Cacodylate buffer, pH 7.4, containing 2.5% glutaraldehyde for 15 min. Samples were rinsed with 0.1M Na-Cacodylate buffer for 10 min and post-fixed in 1% osmium tetraoxide (OsO4) for 60 min. Following ethanol dehydration, the samples were embedded in epoxy resin. Ultra-thin sections were prepared and double-stained with uranyl acetate and lead citrate. Microscopy was performed on a Jeol JEM-1230 instrument (Jeol Ltd., Tokyo, Japan) at the Molecular Imaging Centre (University of Bergen). Pictures were acquired using the GATAN multiscan camera (Gatan Inc, Pleasanton, CA, USA).
Mitochondrial respiration
Oxygen consumption rates were analysed using Oxygraph O2K and DatLab software (Oroboros Instruments, Austria). The oxygen consumption rates were normalized to the number of cells in each chamber. Measurements in intact hepatocytes were performed in RPMI 1640 cell culture medium (without FBS) after sequential additions of oligomycin (1.8µg/ml), carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP) (titrated to maximal activity, titration range 0.1-0.27 mM), rotenone (0.5 µM), antimycin A (2.5 µM).
The respiration medium for permeabilised cells was 0.5 mM EGTA, 3 mM MgCl2•6H2O, 60 mM K-lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose and 1 g/l bovine serum albumin. The additional supplements were malate (1.8 mM), glutamate (9.1 mM), succinate (9.1 mM), digitonin (3.7 µM) and ADP (2.3 mM).
Citrate synthase measurements
Citrate synthase activity was measured in 2x10 5 cells/ml in incubation medium as previously described [24] . 
Flow cytometry
RNA isolation and quantitative real-time PCR
RNA was extracted from tissue samples using RNAeasy Mini kit (Qiagen, Hilden, Germany).
Reverse transcription was performed using High-Capacity Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Quantitative PCR was performed in the LightCycler 480 detection system using the LightCycler 480 Probes master kit (Roche, Basel, Switzerland).
The following genes were analysed using specific FAM probes and primers from Applied 
Mitochondrial DNA quantification
DNA was isolated from primary hepatocytes using DNA Blood and Tissue Kit (Qiagen).
Specific primer for mitochondrial DNA (mtDNA), ND1 (Rn03296764_s1), was purchased from Applied Biosystems and nuclear DNA (nDNA) primer 18S (RT-CKFT-18s) from
Eurogentec. Real-time PCR was carried out on Lightcycler 480 detection system (Roche) and the mtDNA/nDNA ratio was calculated [25] .
Western Blots
Protein concentrations were measured using the Thermo Scientific Pierce BCA Protein Assay Kit (Thermo Scientific Pierce Protein Biology, Rockford, IL, USA). SDS-PAGE and Western blotting were performed using the Invitrogen system, with PVDF membranes.
Detection was done using secondary antibody conjugated to HRP from BioRad Laboratories Inc (Hercules, CA, USA) and ECL Western Blotting Substrate (Thermo Scientific Pierce Protein Biology) in a LAS-3000 imaging system (Fujifilm, Tokyo, Japan). Pixel analysis was performed using Multi Gauge V2.2. software (Fujifilm).
Statistical Analysis
Three independent experiments were performed. Data were analysed using a two sided t-test, and a p-value <0.05 was considered to indicate statistical significance.
Results
Mitochondrial biogenesis coincides with hypertrophy in hepatocytes of TTA-treated rats
The hypolipidemic effect of TTA was first confirmed by measuring levels of cholesterol, triglycerides and phospholipids in blood plasma, after treating the rats for 3 weeks (data not shown). The TTA-treated rats had significantly larger livers (Fig. 1A) , which also was in accordance with previous studies [26] . Hepatocytes were isolated from these livers in order to characterize in more detail the effects of TTA on cellular phenotype and mitochondrial biomass. We found that the hepatocyte protein content tended to increase, although the relatively large standard deviation prevented statistical significance. This was, however, accompanied by higher levels of the mitochondrial biomarkers mtDNA and citrate synthase, of which the latter demonstrated a statistically significant change ( Fig 1A) .
Furthermore, flow cytometry analysis showed that cells from TTA-treated rats were larger (forward scatter, FSC-H), and the cellular granularity was increased (side scatter, SSC-H) (Fig.   1B ).
The cellular morphology was investigated in more detail by transmission electron microscopy ( Fig. 1C) . In accordance with the data above (Fig 1B) , hepatocytes from TTAtreated rats were observed to be larger in size, and have a richer granular content compared to the control cells. Apparently, this included increased number of mitochondria and peroxisomes, as well as glycogen particles indicating alterations in carbohydrate metabolism.
There were also significant changes in the morphology of rough and smooth endoplasmatic reticulum. Observations in isolated hepatocytes correlated with intact liver tissue.
In order to confirm that TTA induced mitochondrial biogenesis, we measured mRNA expression of several associated markers, as well as proteins involved in fatty acid metabolism, in samples from liver. The data demonstrated a moderate increase in two key proteins in mitochondrial biogenesis, NRF-1 and TFAM, as well as mRNA levels of two proteins of the respiratory system, COX and Cyt c (Fig. 1D) . Moreover, increased mRNA expression of CPT-1, CPT-2, CACT and HMGSC-1 indicated upregulation of mitochondrial fatty acid oxidation and ketogenesis. This was also associated with a significant increase in UCP3 expression, confirming previous results [27] . The upregulation of these factors, as well as ACOX-1, supports PPARα activation. These data confirm that TTA induces expression of multiple genes involved in mitochondrial biogenesis and function.
Stimulated mitochondrial respiration in hepatocytes from TTA-treated rats
In order to determine if the observed increase in mitochondrial biogenesis influenced mitochondrial respiratory function, we measured oxygen consumption rates. The data demonstrated that the respiratory rate in RPMI cell culture medium (ROUTINE) was increased 2.6 fold in hepatocytes of TTA-treated rats ( Fig. 2A) . This change was accompanied by increased non-phosphorylating respiration (LEAK), when ATP synthase was inhibited with oligomycin. Furthermore, the capacity of the electron transport system (ETS) was increased 2.5 fold, measured after full uncoupling with FCCP. Interestingly, in contrast to control hepatocytes, a significant fraction of the respiration in intact hepatocytes from TTAtreated rats were independent of respiratory complex I, as observed after addition of the complex I inhibitor rotenone (ETSrot). These data further reveal that both TTA and control cells utilized about 50% of the maximum capacity (ETS) under normal cell culture conditions (ROUTINE). However, the larger fraction of LEAK respiration in TTA-treated rats, suggests that more of the respiratory activity is uncoupled from ATP synthesis.
In order to study the modulation of oxidative phosphorylation in more detail, we permeabilised the cells to allow free flux of substrates into the mitochondria (Fig. 2B) .
Consistent with the findings in intact cells, respiration in presence of malate, glutamate and succinate (MGS) was significantly increased after treatment with TTA. Addition of ADP demonstrated that there was an increase in the oxidative phosphorylation capacity (OXPHOS).
Both the LEAK and ETS respiratory rates were higher, confirming the results in intact cells (Fig 2A) . However, addition of rotenone had minor effect in both cell types. The phosphorylation system control ratio (OXPHOS/ETS) was calculated to 0.45±0.06 and 0.81±0.18 in control and TTA-treated cells, respectively, suggesting that the limitation of electron flux exerted by the phosphorylation system was reduced.
TTA-treatment activates mTOR signalling in rat liver
The hypertrophic response in hepatocytes of TTA-treated rats was found to be accompanied by an increase in mitochondrial biomass and oxidative capacity. We further examined if these effects were associated with regulation of Akt, ERK1/2 and mTOR, three key signalling factors of cell homeostasis and adaptation. Flow cytometry analysis indicated that expression of mTOR was increased (Fig. 3A) , and activation of this pathway was supported by increased phosphorylation of the downstream actors 4E-BP1 and eIF4G, as demonstrated by western blotting (Fig. 3B) . The protein levels of these factors were also increased. The level of Akt was unchanged or slightly reduced, but we observed a minor increase in phosphorylation at Ser473 (Fig. 3A) . Finally, we found that the protein level and phosphorylation of ERK1/2 was increased in TTA treated rats; although statistics could not be calculated since we only had samples from two rats in each group for this analysis (Fig. 3B ).
Discussion
This work demonstrates that the significant increase in mitochondrial oxidation capacity observed in rat hepatocytes after treatment with TTA can be explained by induction of mitochondrial biogenesis accompanied by increased mitochondrial respiration. The adaptive mechanism involved PPAR-activation in addition to signalling via ERK1/2 and mTOR, and was associated with cellular hypertrophy.
Previous studies have demonstrated that the modified fatty acid TTA act as a pan-PPAR activator and regulate processes of lipid and energy metabolism in animals [17, 18, 19, 20] . Activation of PPARα was confirmed by upregulated mRNA expression of ACOX, CPT II and UCP3, representing target genes of this transcription factor [27, 28] .
Furthermore, our study showed that the increased liver weight involved cellular organelle amplifications, a known stress response after increased functional load in the liver [29] . The increase in hepatocyte cell size, granularity and protein content was consistent with cellular hypertrophy. Hypertrophy is a well-known effect of PPARα activation that seems restricted to rodents and not humans [30] . Induction of mitochondrial biogenesis was confirmed by measuring mtDNA, citrate synthase activity and mRNA expression of mitochondrial proteins.
Although the morphology appeared less organized in samples from TTA-treated rats, there were no signs of cellular toxicity and the biochemical function was intact. Previous data from long term rat experiments (50 weeks) [27] and clinical studies [31] have shown that TTA is well tolerated.
This study suggest that mTOR, possibly via interaction with ERK1/2 and Akt, may be involved in an adaptive stress response leading to hypertrophy and mitochondrial biogenesis in hepatocytes after treatment with TTA. This may share similarity with the adaptive signalling response of mitochondrial biogenesis observed in muscle after exercise [32] .
Furthermore, TTA has effects in common fasting condition, including increased fatty acid oxidation and ketogenesis, which have been associated with PGC1α [33] , another player in the mTOR network [34] . Moreover, recently mTORC1 was shown to act together with PPARα in the regulation of fasting-induced ketogenesis [7] , whereas in adipocytes, PPARγ interacts with mTOR to regulate hypertrophy [35] . These findings suggest that the observed effects of TTA might involve crosstalk between PPARs and mTOR.
Mitochondrial respiration was significantly increased together with induction of mitochondrial biogenesis in rat hepatocytes after treatment with TTA. This included increased capacities of the ETS as well as OXPHOS. However, whereas ADP-induced respiration closely balanced the ETS capacity in hepatocytes from TTA-treated rats, the ETS capacity exceeded the ADP-induced respiration in control hepatocytes. This suggests that the capacity to phosphorylate ADP to ATP is selectively strengthened in TTA-treated hepatocytes.
Furthermore, the uncoupled respiration (LEAK) was increased after the treatment, supporting previous studies of fatty acid-driven respiration [20] . Whether or not this is associated with the significant up-regulation of UCP3 remains unclear since the role of this protein is still unknown. However, potential functions are related to metabolic balancing [36] as well as handling of reactive oxygen species (ROS) [37] . We also observed a significantly increased fraction of rotenone-insensitive respiration. This may be associated with the high rates of fatty acid β-oxidation, feeding electrons into the ubiquinone pool via the ETFP-ubiquinone oxidoreductase [38] , thereby bypassing the rotenone sensitive complex I.
In summary, these results suggest that the increased mitochondrial biogenesis and respiration in rat hepatocytes after treatment with TTA involves coordinated regulation of oxidative metabolism via PPARs in association with a hypertrophic response possibly mediated via mTOR. How these pathways may interact under these conditions is yet to be determined. Our results also highlight the extensive adaptability of hepatic mitochondria under metabolically demanding conditions. 
